Molecular Targets for 17α-Ethynyl-5-Androstene-3β,7β,17β-Triol, an Anti-Inflammatory Agent Derived from the Human Metabolome
Authors:
Open Access
- 24 February 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (2) , e32147
Abstract
HE3286, 17α-ethynyl-5-androstene-3β, 7β, 17β-triol, is a novel synthetic compound related to the endogenous sterol 5-androstene-3β, 7β, 17β-triol (β-AET), a metabolite of the abundant adrenal steroid dehydroepiandrosterone (DHEA). HE3286 has shown efficacy in clinical studies in impaired glucose tolerance and type 2 diabetes, and in vivo models of types 1 and 2 diabetes, autoimmunity, and inflammation. Proteomic analysis of solid-phase HE3286-bound bead affinity experiments, using extracts from RAW 264.7 mouse macrophage cells, identified 26 binding partners. Network analysis revealed associations of these HE3286 target proteins with nodes in the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways for type 2 diabetes, insulin, adipokine, and adipocyte signaling. Binding partners included low density lipoprotein receptor-related protein (Lrp1), an endocytic receptor; mitogen activated protein kinases 1 and 3 (Mapk1, Mapk3), protein kinases involved in inflammation signaling pathways; ribosomal protein S6 kinase alpha-3 (Rsp6ka3), an intracellular regulatory protein; sirtuin-2 (Sirt2); and 17β-hydroxysteroid dehydrogenase 1 (Hsd17β4), a sterol metabolizing enzyme.Keywords
This publication has 37 references indexed in Scilit:
- Apolipoprotein E Induces Antiinflammatory Phenotype in MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouseEuropean Journal of Pharmacology, 2011
- Studies of the pharmacology of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol, a synthetic anti-inflammatory androstene.2011
- HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppressionJournal of Inflammation, 2010
- Amelioration of Glucose Intolerance by the Synthetic Androstene HE3286: Link to Inflammatory PathwaysThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Comparative analysis to guide quality improvements in proteomicsNature Methods, 2009
- Inactivation of the LRP1 Intracellular NPxYxxL Motif in LDLR-Deficient Mice Enhances Postprandial Dyslipidemia and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- An Orally Bioavailable Synthetic Analog of an Active Dehydroepiandrosterone Metabolite Reduces Established Disease in Rodent Models of Rheumatoid ArthritisThe Journal of Pharmacology and Experimental Therapeutics, 2009
- Identifying the proteins to which small-molecule probes and drugs bind in cellsProceedings of the National Academy of Sciences, 2009
- Analysis of Quantitative Proteomic Data Generated via Multidimensional Protein Identification TechnologyAnalytical Chemistry, 2002